Articles by James Calloway
Plug Power Soars on Q4 Profit, New CEO Outlines Liquidity Plan
Plug Power shares jumped 23% following a stronger-than-expected Q4, which delivered a $5.5 million gross profit. The company also detailed plans to bolster liquidity through asset sales.
FDA Issues Second Ozempic Ad Warning to Novo Nordisk in Escalating Scrutiny
The FDA has sent Novo Nordisk a second advertising violation notice in under a month, citing misleading claims for Ozempic. The agency simultaneously warned 30 telehealth companies about compounded GLP-1 drug promotions.
Target Unveils $5B Revamp Plan Amid Sales Slump, Shares Rally
Target Corporation is boosting its 2026 capital spending to $5 billion, adding over 30 new stores and 130 remodels. The retailer reported a 1.5% drop in Q4 net sales but shares jumped nearly 7% on the strategic outlook.
Vistry Plunges on Margin Outlook, Leadership Transition
Vistry Group stock tumbled more than 20% as the UK homebuilder warned of compressed margins for 2026 and revealed its executive chair will step down, with debt reduction taking priority over shareholder returns.
Wix Secures $250M Investment, Posts Mixed Q4 Results, and Unveils 2026 Outlook
Wix has entered into a $250 million private placement agreement and reported fourth-quarter revenue of $524.3 million, a 14% increase. The company also issued a 2026 outlook projecting mid-teens growth.
Adidas Shares Slide on 2026 Profit Guidance Miss, CEO Contract Extended
Adidas AG shares dropped sharply after the company projected 2026 operating profit of approximately €2.3 billion, missing analyst expectations. The sportswear giant pointed to U.S. import tariffs and a weaker dollar as primary challenges.
CrowdStrike Posts Strong Q4, Guides Higher Amid AI Security Focus
CrowdStrike Holdings reported fourth-quarter results that exceeded profit expectations and raised its annual recurring revenue target. The cybersecurity firm also issued forward-looking revenue guidance for fiscal 2027 and disclosed new share repurchases.
Lilly Shares Decline Ahead of Key FDA Obesity Pill Decision
Eli Lilly shares declined for a second day as the market anticipates an FDA decision on its oral obesity treatment in April. The FDA also issued warnings to telehealth firms marketing compounded weight-loss drugs.
CrowdStrike Stock Gains on Strong Q4 Results and Upbeat Long-Term Targets
CrowdStrike reported better-than-expected fourth-quarter results, with annual recurring revenue exceeding $5 billion. The company provided a robust long-term forecast through fiscal 2027, sending shares higher in extended trading.
Broadcom Shares Dip Ahead of Q1 Report Amid RBC Target Cut, AI Demand Scrutiny
Broadcom shares declined 1.6% to $313.84 Tuesday, with RBC Capital reducing its price target to $340 from $370 ahead of the chipmaker's quarterly results. The market is focused on AI infrastructure spending durability and VMware software growth.
Adobe Shares Surge Ahead of Q1 Earnings, AI Monetization in Focus
Adobe shares gained 4.1% on Tuesday, defying broader market weakness, as investors look to the company's upcoming earnings report for clarity on AI monetization and acquisition progress.